Finance

Lists
Why is MCRB up 3.80%?
Dive Deeper
MCRB:NASDAQ
Seres Therapeutics Inc
$ 2.73
+3.80%
(+0.100) 1D
10-р сарын 9, 15:30:03 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCRB...
Open
$ 2.65
High
$ 2.75
Low
$ 2.58
Mkt. cap
27.14 сая
Avg. vol.
68.95 мян
Volume
59.85 мян
52-wk high
$ 29.98
52-wk low
$ 2.42
EPS
-$ 2.33
Beta
0.31
Shares outstanding
9.94 сая
No. of employees
66
Open
$ 2.65
High
$ 2.75
Low
$ 2.58
Mkt. cap
27.14 сая
Avg. vol.
68.95 мян
Volume
59.85 мян
52-wk high
$ 29.98
52-wk low
$ 2.42
EPS
-$ 2.33
Beta
0.31
Shares outstanding
9.94 сая
No. of employees
66
News stories
From web sources and news partners
About Seres Therapeutics Inc
CEOEric Shaff
Employees66
Founded2010
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to MCRB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MCRB in the last 3 months.
Highest
Current $ 2.73
$ 22.00 (+705.86%)
Average
$ 17.00 (+522.71%)
Lowest
$ 12.00 (+339.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
$ 22.00
+705.9%
08/06/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$ 12.00
+339.6%
08/05/2026
Edward Tenthoff
Piper Sandler
Hold
Maintained
$ 20.00
+632.6%
02/13/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
11/05/2025
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
$ 1.07 / -$ 2.18
+148.77%beat
Revenue / Est. (USD)
736.00 мян / 358.00 мян
+105.59%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
351.00 мян
438.00 мян
358.00 мян
736.00 мян
Cost of goods sold
13.35 сая
12.28 сая
13.20 сая
9.14 сая
Cost of revenue
13.35 сая
12.28 сая
13.20 сая
9.14 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.48 сая
7.54 сая
8.07 сая
7.06 сая
Operating expense
9.48 сая
7.54 сая
8.07 сая
7.06 сая
Total operating expenses
22.83 сая
19.82 сая
21.26 сая
16.20 сая
Operating income
-22.48 сая
-19.38 сая
-20.91 сая
-15.47 сая
Other non operating income
2.84 сая
2.33 сая
669.00 мян
673.00 мян
EBT including unusual items
8.20 сая
-15.34 сая
-19.91 сая
4.58 сая
EBT excluding unusual items
-19.02 сая
-16.60 сая
-19.91 сая
-14.61 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
8.20 сая
-15.34 сая
-19.91 сая
4.58 сая
Net profit margin
2,337.32%
-3,501.14%
-5,562.29%
622.42%
Earnings per share
0.94
-1.76
-2.08
1.07
Interest and investment income
618.00 мян
445.00 мян
325.00 мян
181.00 мян
Interest expense
-
-
-
-
Net interest expenses
618.00 мян
445.00 мян
325.00 мян
181.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.43 сая
-18.42 сая
-20.13 сая
-14.80 сая
Gain or loss from assets sale
-
-192.00 мян
-
139.00 мян
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс